Commentary

Published in:
Volume 6 / Year 2017 / Issue 3

Patent expiry and costs for antiĀ­cancer medicines for clinical use

Author(s): , ,
Page: 105-6

Abstract: Venkatesan S et al. have researched patent rights and pricing for (non-)tyrosine kinase inhibitors. It is not clear why the patent rights are so long and why prices of… Read More »

Go Back Print